Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Topoisomerase-targeting antitumor drugs: mechanisms of cytotoxicity and resistance.

× No keyword cloud information.

12 in total

1. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.

Authors: A Kathleen McClendon; Neil Osheroff
Journal: Biochemistry Date: 2006-03-07 Impact factor: 3.162

2. Determining success rates of the current pharmacokinetically guided dosing approach of topotecan in pediatric oncology patients.

Authors: Anna Birg Mitchell; Aksana Vasilyeva; Amar Gajjar; Victor M Santana; Clinton F Stewart
Journal: Pediatr Blood Cancer Date: 2018-12-11 Impact factor: 3.167

3. SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage.

Authors: Y Mao; M Sun; S D Desai; L F Liu
Journal: Proc Natl Acad Sci U S A Date: 2000-04-11 Impact factor: 11.205

4. Rad18 E3 ubiquitin ligase activity mediates Fanconi anemia pathway activation and cell survival following DNA Topoisomerase 1 inhibition.

Authors: Komaraiah Palle; Cyrus Vaziri
Journal: Cell Cycle Date: 2011-05-15 Impact factor: 4.534

5. Human topoisomerase I mediates illegitimate recombination leading to DNA insertion into the ribosomal DNA locus in Saccharomyces cerevisiae.

Authors: J Zhu; R H Schiestl
Journal: Mol Genet Genomics Date: 2004-03-06 Impact factor: 3.291

Review 6. Topoisomerase II in multiple drug resistance.

Authors: G A Hofmann; M R Mattern
Journal: Cytotechnology Date: 1993 Impact factor: 2.058

Review 7. DNA topoisomerase II, genotoxicity, and cancer.

Authors: A Kathleen McClendon; Neil Osheroff
Journal: Mutat Res Date: 2007-07-03 Impact factor: 2.433

8. Mechanism of Action of Mycobacterium tuberculosis Gyrase Inhibitors: A Novel Class of Gyrase Poisons.

Authors: Elizabeth G Gibson; Tim R Blower; Monica Cacho; Ben Bax; James M Berger; Neil Osheroff
Journal: ACS Infect Dis Date: 2018-05-17 Impact factor: 5.084

Review 9. Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical development.

Authors: C J Gerrits; M J de Jonge; J H Schellens; G Stoter; J Verweij
Journal: Br J Cancer Date: 1997 Impact factor: 7.640

10. Importance of the fourth alpha-helix within the CAP homology domain of type II topoisomerase for DNA cleavage site recognition and quinolone action.

Authors: Dirk Strumberg; John L Nitiss; Jiaowang Dong; Jerrylaine Walker; Marc C Nicklaus; Kurt W Kohn; Jonathan G Heddle; Anthony Maxwell; Siegfried Seeber; Yves Pommier
Journal: Antimicrob Agents Chemother Date: 2002-09 Impact factor: 5.191